Article
Recent Federal Developments Targeting China-Linked Companies And Overseas Biotechnology Investments And Collaboration
Congress and the Administration are rapidly escalating scrutiny of China-linked biotechnology operations through new legislation targeting patents, investments, and procurement.
Foley Hoag LLP